Quantitative Proteomics of Urinary Bladder Cancer Cell Lines Identify UAP1 as a Potential Therapeutic Target
Bladder carcinoma (BC) incidence and mortality rates are increasing worldwide. The development of novel therapeutic strategies is required to improve clinical management of this cancer. Aberrant protein expression may lead to cancer initiation and progression. Therefore, the identification of these...
Main Authors: | Vinuth N. Puttamallesh, Barnali Deb, Kirti Gondkar, Ankit Jain, Bipin Nair, Akhilesh Pandey, Aditi Chatterjee, Harsha Gowda, Prashant Kumar |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-07-01
|
Series: | Genes |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4425/11/7/763 |
Similar Items
-
Verification of molecular subtyping of bladder cancer in the GUSTO clinical trial
by: Jon Griffin, et al.
Published: (2024-03-01) -
Expression of Vitamin D Receptor (VDR) in Urinary Bladder Carcinoma: Immunohistochemical and Histopathological Study
by: Rehab Mohamed Sharaf, et al.
Published: (2022-09-01) -
Integrated Proteomic and Phosphoproteomics Analysis of DKK3 Signaling Reveals Activated Kinase in the Most Aggressive Gallbladder Cancer
by: Kirti Gondkar, et al.
Published: (2021-02-01) -
Urinary-Based Markers for Bladder Cancer Detection
by: Tilman Todenhöfer, Michele Lodde, Kim van Kessel, Renate Pichler, Antonia Vlahou, Yair Lotan
Published: (2020-10-01) -
Molecular classification of muscle-invasive bladder cancer based on a simplified immunohistochemical panel using GATA3, CK5/6 and p16
by: Robert Terlević, et al.
Published: (2023-11-01)